Read More

EXCLUSIVE: Coya Therapeutics, Focused On Neurodegenerative Diseases Has Gained 70% Since IPO; CEO Highlights Efforts On Combination Therapy For Rare Diseases

Coya Therapeutics is working On neurodegenerative disease treatment with its combination therapies targeting regulatory T cells. CEO Howard Berman discusses the potential of COYA 302 for ALS, FTD, Parkinson's, and Alzheimer's, emphasizing a transformative approach to immune balance restoration.

BBIB

Read More

Sustainable Cannabis In Coachella Valley: Green Horizons’ 1M Sq Ft Facility, Tommy Hilfiger CPG Expansion

In an exclusive interview with Benzinga Cannabis, Carlos "Los" Arias, co-founder of California marijuana company Green Horizons, discussed the company's innovative approach to cultivation and margins, emphasizing sustainability and cost efficiencies at the company's new facility in Coachella Valley.

PVH